Export 10 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Mice  [Clear All Filters]
2022
Venkatesan V, Christopher ACrystal, Karuppusamy KV, Babu P, Alagiri MKumar K, Thangavel S.  2022.  CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications.. J Vis Exp. (186) DOI:10.3791/64064.
Bagchi A, Devaraju N, Chambayil K, Rajendiran V, Venkatesan V, Sayed N, Pai AAnand, Nath A, David E, Nakamura Y, Balasubramanian P, Srivastava A, Thangavel S, Mohankumar KM, Velayudhan SR.  2022.  Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications.. Sci Rep. 12(1):14033. DOI:10.1038/s41598-022-13783-0.
Devaraju N, Rajendiran V, Ravi NSam, Mohankumar KM.  2022.  Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System.. Methods Mol Biol. 2429:307-331. DOI:10.1007/978-1-0716-1979-7_20.
Ghosh S, Singh R, Vanwinkle ZMatthew, Guo H, Vemula PKumar, Goel A, Haribabu B, Jala VRao.  2022.  Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.. Theranostics. 12(12):5574-5595. DOI:10.7150/thno.70754.
Christopher ACrystal, Venkatesan V, Karuppusamy KV, Srinivasan S, Babu P, Azhagiri MKumar K, Chambayil K, Bagchi A, Rajendiran V, Ravi NSam, Kumar S, Marepally SKumar, Mohankumar KMurugesan, Srivastava A, Velayudhan SR, Thangavel S.  2022.  Preferential Expansion of Human CD34CD133CD90 Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy.. Hum Gene Ther. 33(3-4):188-201. DOI:10.1089/hum.2021.089.